Reviewing case reports and the droperidol warning: FDA response.
Division of Anesthetic, Critical Care, and Addiction Drug Products Center for Drug Evaluation and Research Food and Drug Administration Rockville, MD.
Nancy
N
Chang
Arthur
A
Simone
Lester
L
Schultheis
Bob
B
Rappaport
D000759:Adjuvants, Anesthesia / Q000008:administration & dosage / Q000009:adverse effects*; D004329:Droperidol / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007275:Injections, Intravenous; D008133:Long QT Syndrome / Q000139:chemically induced*; D011358:Product Surveillance, Postmarketing; D014481:United States; D014486:United States Food and Drug Administration
D000759:Adjuvants, Anesthesia; D004329:Droperidol